Disrupted superior collicular activity may reveal cervical dystonia disease pathomechanisms
Objective: To assess by functional magnetic resonance imaging, the response of the superior colliculi to a looming stimulus in cervical dystonia patients and their unaffected…Pattern and Predictors Of Tremor In Patients With Primary Dystonia
Objective: To assess the frequency, location and predictors of tremor in Indian patients with primary dystonia. Background: Tremor is now recognized to be a frequent…Improvement in hand tremor following carpal tunnel release surgery
Objective: OBJECTIVE: To describe a case of a dystonic tremor improvement following treatment of a peripheral nerve lesion, in this case carpal tunnel release surgery.…Falls in Parkinson’s disease are related to delayed recovery time after unexpected external perturbations
Objective: The aim of this study was to analyze the postural adjustments in fallers and non-fallers Parkinson’s disease (PD) patients. Background: Adequate reactive postural response…Characterization of Pisa syndrome in Parkinson’s disease.
Objective: This study has two main objectives. The first objective is to elucidate the effects of distraction and alteration of sensorimotor inputs (visual and proprioceptive…Optimization and evaluation of whole body MRI sequences for patients with deep brain stimulators
Objective: The aim of the study was to optimize MRI sequences in order to make possible a safe MRI examination for DBS patients. The optimized…Noladin ether attenuates MPTP -induced motor deficit by abrogating pro-inflammatory cytokines and striatal neurochemical alterations in rats
Objective: The present study was designed to investigate the therapeutic potential of noladin ether- a putative endocannabinoid against MPTP-induced behavioral, biochemical and neurochemical alterations in…Real World Clinical Outcomes Using a Novel Directional Lead from a Multicenter Registry of DBS for Parkinson’s disease
Objective: To evaluate clinical outcomes in subjects implanted with a Directional Lead for use in the treatment of levodopa-responsive Parkinson’s disease (PD) as part of…Levodopa effect and motor function in late stage Parkinson’s disease
Objective: To assess responsiveness to Levodopa (L-dopa) in patients with late stage Parkinson’s disease (PD). Moreover, to investigate if the L-dopa effect is stable or…Baseline characteristics of the population enrolled to a randomized clinical study of subcutaneous levodopa/carbidopa (ND0612) infusion in patients with advanced PD
Objective: To evaluate whether continuous 24 hours delivery of subcutaneous ND0612 offers practical and clinical benefits over continuous delivery over the waking day (14 hours).…
- « Previous Page
- 1
- …
- 140
- 141
- 142
- 143
- 144
- …
- 155
- Next Page »